Recursion Pharmaceuticals, Inc. Class A Common Stock (NASDAQ: RXRX) last traded at $4.36, up 10.38% on the session. The quote above updates while this page is open; the figures below are drawn from Recursion Pharmaceuticals, Inc. Class A Common Stock’s own filings and are restated only when a new one is published.
Recursion Pharmaceuticals, Inc. Class A Common Stock trades on NASDAQ under the ticker RXRX. Its market capitalisation is $2.33 billion.
Valuation measures for Recursion Pharmaceuticals, Inc. Class A Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $2.33B |
|---|---|
| Enterprise value | $2.09B |
| Price / sales | 42.55 |
| Price / book | 2.55 |
| Beta | 2.87 |
Trailing-twelve-month figures tagged in Recursion Pharmaceuticals, Inc. Class A Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $54.85M |
|---|---|
| Net income (TTM) | -$518.88M |
| EPS (TTM) | -$1.00 |
| Gross margin | 3.48% |
| Operating margin | -991.72% |
| Return on equity | -56.71% |
| Cash | $545.68M |
Range and volume for RXRX over the past 52 weeks.
| 52-week high | $7.18 |
|---|---|
| 52-week low | $2.77 |
| Volume | 35.50M |
| Average volume | 20.92M |
| Previous close | $3.95 |
Invest a chosen dollar amount in Recursion Pharmaceuticals, Inc. Class A Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell RXRX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.